Open AccessArtemether-Lumefantrine Treatment Failure in Nonimmune European Travelers With Plasmodium falciparum Malaria: Do We Need to Reconsider Dosing in Patients From Nonendemic Regions?
Author(s) -
Andreas Neumayr,
Daniel H. Paris,
Blaise Genton,
Christoph Hatz
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix262
Subject(s) - artemether/lumefantrine , medicine , plasmodium falciparum , dosing , malaria , artemether , lumefantrine , intensive care medicine , immunology , pharmacology , artemisinin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom